Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-010841

Exec. VP Chief Legal Officer sold 3,926 shares at $17.74 ($69,647)

  • Exec. VP Chief Legal Officer acquired 3,926 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stark David Matthew · Exec. VP Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-14 Exercise or conversion : show line 1 in the form +3,926 6,900.39 D
2019-02-14 Sale : show line 2 in the form −3,926 $17.74 $69,647 2,974.39 D
Open-market sales · 3,926 sh · avg $17.74 · $69,647

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-14 Exercise or conversion : show line 3 in the form Restricted Share Units −3,926 7,852 D
Loading xslF345X03/doc4.xml…